For: | Li Y, Zhao ZG, Luo Y, Cui H, Wang HY, Jia YF, Gao YT. Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis repeat-containing 5 in TP53-mutated hepatocellular carcinoma. World J Gastroenterol 2020; 26(32): 4786-4801 [PMID: 32921957 DOI: 10.3748/wjg.v26.i32.4786] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v26/i32/4786.htm |
Number | Citing Articles |
1 |
Aadil Javed, Gianluca Malagraba, Mahdieh Yarmohammadi, Catalina M. Perelló-Reus, Carles Barceló, Teresa Rubio-Tomás. Therapeutic Potential of Mitotic Kinases’ Inhibitors in Cancers of the Gastrointestinal System. Future Pharmacology 2022; 2(3): 214 doi: 10.3390/futurepharmacol2030015
|
2 |
Yuyao Li, Yue Li, Xuemei Zhang, Xiangjuan Duan, Hai Feng, Zhuo Yu, Yueqiu Gao. A novel association of pyroptosis-related gene signature with the prognosis of hepatocellular carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.986827
|
3 |
Keying Liang, Qian Wang, Li Qiu, Xiaocheng Gong, Zixi Chen, Haibo Zhang, Ke Ding, Yunfei Liu, Jinfen Wei, Shudai Lin, Shuying Fu, Hongli Du. Combined Inhibition of UBE2C and PLK1 Reduce Cell Proliferation and Arrest Cell Cycle by Affecting ACLY in Pan-Cancer. International Journal of Molecular Sciences 2023; 24(21): 15658 doi: 10.3390/ijms242115658
|
4 |
阳春 胡. Quercetin Targeting BIRC5 Inhibits the Proliferation of Glioblastoma and Affects the Prognosis Based on Bioinformatics and Network Pharmacology Analysis. Advances in Clinical Medicine 2023; 13(01): 928 doi: 10.12677/ACM.2023.131134
|
5 |
Qiu-Ju Liang, Qin-Qin Long, Feng-Qin Tian, Xi-Dai Long. Progress in research of polo-like kinase 1 in hepatocellular carcinoma. World Chinese Journal of Digestology 2024; 32(9): 652 doi: 10.11569/wcjd.v32.i9.652
|
6 |
Chao Yang, Dan Li, Shaohong Zang, Lei Zhang, Zhangfeng Zhong, Yingtang Zhou. Mechanisms of carcinogenic activity triggered by lysine-specific demethylase 1A. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.955218
|
7 |
Honghao Yang, Yilan Zhao, Xiaojiao Zheng, Xiulian Ju, Fengshou Wu, Xiaogang Luo, Qi Sun, Genyan Liu. Exploring Novel PLK1 Inhibitors based on Computational Studies of
2,4-Diarylaminopyrimidine Derivatives. Letters in Drug Design & Discovery 2024; 21(5): 979 doi: 10.2174/1570180820666230801114905
|
8 |
Shengqin Su, Gagan Chhabra, Chandra K. Singh, Mary A. Ndiaye, Nihal Ahmad. PLK1 inhibition-based combination therapies for cancer management. Translational Oncology 2022; 16: 101332 doi: 10.1016/j.tranon.2021.101332
|
9 |
Yan Li, William Lee, Zhen-Gang Zhao, Yi Liu, Hao Cui, Hao-Yu Wang. Fatty acid binding protein 5 is a novel therapeutic target for hepatocellular carcinoma. World Journal of Clinical Oncology 2024; 15(1): 130-144 doi: 10.5306/wjco.v15.i1.130
Abstract(471) |
Core Tip(502) |
Full Article(HTML)(2222)
|
Full Article with Cover (PDF)-10479K(127)
|
Full Article (Word)-5042K(15)
|
Audio-1357K(5)
|
Peer-Review Report-191K(59)
|
Answering Reviewers-385K(68)
|
Supplementary Material-706K(70)
|
Full Article (PDF)-10155K(108)
|
Full Article (XML)-97K(65)
|
Times Cited (0)
|
Total Visits (5785)
|
Open
|
10 |
Xuan Wu, Shen-Ying Yang, Yi-Hua Zhang, Jin-Zhou Fang, Shuai Wang, Zhi-Wei Xu, Xiao-Ju Zhang. Prognostic and immunological roles of heat shock protein A4 in lung adenocarcinoma. World Journal of Clinical Oncology 2024; 15(1): 45-61 doi: 10.5306/wjco.v15.i1.45
Abstract(486) |
Core Tip(514) |
Full Article(HTML)(2855)
|
Full Article with Cover (PDF)-9899K(81)
|
Full Article (Word)-3948K(12)
|
Audio-863K(7)
|
Peer-Review Report-179K(69)
|
Answering Reviewers-3K(63)
|
Supplementary Material-100K(67)
|
Full Article (PDF)-9576K(96)
|
Full Article (XML)-108K(65)
|
Times Cited (0)
|
Total Visits (7043)
|
Open
|